Indaptus Therapeutics, Inc. (INDP) stock
INDPNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.17+0.02 (+0.63%)
Close on Nov 13, 2026Market cap $422.38MP/E –Yield –
Indaptus Therapeutics total assets
Total assets on the balance sheet at the end of each period.
Indaptus Therapeutics's total assets was $31.21M at Sep 30, 2026. For fiscal 2025 it was $9.31M, up 26.9% from the year before. The highest annual figure on record is $40.58M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.31M | +26.9% |
| FY2024 | Dec 31, 2024 | $7.34M | -50.8% |
| FY2023 | Dec 31, 2023 | $14.92M | -46.8% |
| FY2022 | Dec 31, 2022 | $28.06M | -30.8% |
| FY2021 | Dec 31, 2021 | $40.58M | +2182.4% |
| FY2020 | Dec 31, 2020 | $1.78M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $31.21M | +356.4% |
| Q2 FY2026 | Jun 30, 2026 | $11.99M | +121.5% |
| Q4 FY2025 | Dec 31, 2025 | $9.31M | +26.9% |
| Q3 FY2025 | Sep 30, 2025 | $6.84M | -17.0% |
| Q2 FY2025 | Jun 30, 2025 | $6.84M | -15.8% |
| Q1 FY2025 | Mar 31, 2025 | $5.41M | -50.6% |
| Q4 FY2024 | Dec 31, 2024 | $7.34M | -50.8% |
| Q3 FY2024 | Sep 30, 2024 | $8.24M | -53.7% |
| Q2 FY2024 | Jun 30, 2024 | $8.12M | -61.0% |
| Q1 FY2024 | Mar 31, 2024 | $10.95M | -52.7% |
| Q4 FY2023 | Dec 31, 2023 | $14.92M | -46.8% |
| Q3 FY2023 | Sep 30, 2023 | $17.79M | -41.6% |
| Q2 FY2023 | Jun 30, 2023 | $20.84M | -38.8% |
| Q1 FY2023 | Mar 31, 2023 | $23.14M | -37.6% |
| Q4 FY2022 | Dec 31, 2022 | $28.06M | -30.8% |
| Q3 FY2022 | Sep 30, 2022 | $30.45M | -30.6% |
| Q2 FY2022 | Jun 30, 2022 | $34.06M | +69.5% |
| Q1 FY2022 | Mar 31, 2022 | $37.09M | +1986.1% |
| Q4 FY2021 | Dec 31, 2021 | $40.58M | – |
| Q3 FY2021 | Sep 30, 2021 | $43.86M | – |
| Q2 FY2021 | Jun 30, 2021 | $20.09M | – |
| Q4 FY2020 | Dec 31, 2020 | $1.78M | – |
See a number that looks wrong?